Approval · Notice of Compliance 3502 · 2003
ALTACE: Notice of Compliance 3502
Issued November 6, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3502
- Date
- November 6, 2003
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the action and clinical pharmacology section of the product monograph with regards to management of patients with increased risk of cardiovascular events
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALTACE | Not yet assigned | — |